Supriya Lifescience Limited — Board Meeting, 27-05-2026: Outcome of Board Meeting

Supriya Lifescience's board approved audited financial results for the quarter and year ended March 31, 2026, with revenue of ₹827.88 Cr and profit of ₹209.12 Cr for the year. The board also proposed a final dividend of ₹1.00 per equity share (50% on ₹2/- face value), pending shareholder approval.